Blue Star Capital
BLU · AIM · Financial Services · mcap £2.0m · 4.0p
- Revenue
- –
- Operating profit
- −£1.1m
- Net income
- −£1.1m
- Free cash flow
- −£246k
- Net cash
- £80k
- Market cap
- £2.0m
- EV / EBIT
- –
- FCF yield
- −12.0%
- Price / book
- 0.9×
- Revenue
- £0k prior £0k
- Operating profit
- −£577k prior −£108k
- Net income
- −£576k prior −£108k
- Cash from operations
- −£115k prior −£85k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Half-year Results, published 30 Jun 26 · read the announcement ↗
Statement of Comprehensive Income · for the six months ended 31 March 2026 · Unaudited Audited · Six months ended 31 March Year ended 30 September
| 2026 £ | 2025 £ | 2024 £ | |
|---|---|---|---|
| Revenue | - | - | - |
| Fair valuation movements in financial instruments designated at fair value through profit or loss | 2,402 | (1,014) | (346,928) |
| 2,402 | (1,014) | (346,928) | |
| Loss on settlement of loan receivable | (440,058) | - | - |
| Share based payment | (40,248) | (42,064) | (126,700) |
| Administrative expenses | (98,672) | (64,739) | (193,257) |
| Operating loss | (576,576) | (107,817) | (666,885) |
| Finance income | 298 | 187 | 1,279 |
| Loss before and after taxation and total comprehensive income for the period | (576,278) | (107,630) | (665,606) |
| Loss per ordinary share | |||
| Basic and diluted loss per share | (1.21p) | (0.37p) | (1.93p) |
Statement of Financial Position · as at 31 March 2026 · Unaudited Audited · Six months ended 31 March Year ended 30 September
| 2026 £ | 2025 £ | 2025 £ | |
|---|---|---|---|
| Non-current assets | |||
| Financial assets at fair value through profit or loss | 2,250,100 | 1,032,384 | 1,553,643 |
| 2,250,100 | 1,032,384 | 1,553,643 | |
| Current assets | |||
| Loan receivable | - | - | 1,015,246 |
| Trade and other receivables | 19,576 | 15,622 | 11,252 |
| Cash and cash equivalents | 79,698 | 30,209 | 313,236 |
| 99,274 | 45,831 | 1,339,734 | |
| Total assets | 2,349,374 | 1,078,215 | 2,893,377 |
| Current liabilities | |||
| Trade and other payables | 19,509 | 34,400 | 27,482 |
| Total liabilities | 19,509 | 34,400 | 27,482 |
| Net assets | 2,329,865 | 1,043,815 | 2,865,895 |
| Shareholders' equity | |||
| Share capital | 47,554 | 33,814 | 47,554 |
| Share premium account | 11,920,403 | 9,738,722 | 11,920,403 |
| Deferred shares | 5,067,309 | 4,967,310 | 5,067,309 |
| Other reserves | 166,948 | 285,312 | 126,700 |
| Retained earnings | (14,872,349) | (13,981,343) | (14,296,071) |
| 2,329,865 | 1,043,815 | 2,865,895 | |
Statement of cash flows · for the six months ended 31 March 2026 · Unaudited Audited · Six months ended 31 March Year ended 30 September
| 2026 £ | 2025 £ | 2025 £ | |
|---|---|---|---|
| Operating activities | |||
| Loss for the period | (576,278) | (107,630) | (665,606) |
| Adjustments for | |||
| Finance income | (298) | (187) | (1,279) |
| Fair value gains/(losses) | (2,402) | 1,014 | 346,928 |
| Loss on settlement of loan receivable | 440,058 | - | - |
| Share based payment | 40,248 | 42,064 | 126,700 |
| Working capital adjustments | |||
| Increase in trade and other receivables | (8,324) | (12,314) | (7,943) |
| Decrease in trade and other payables | (7,973) | (7,749) | (14,667) |
| Net cash used in operating activities | (114,969) | (84,802) | (215,867) |
| Investing activities | |||
| Purchase of safe note 1 | (218,996) | (63,004) | (63,004) |
| Loan given to SatoshiPay | - | - | (1,000,000) |
| Loan repayment received from SatoshiPay | 100,129 | - | - |
| Interest received | 298 | 187 | 1,279 |
| Net cash used in investing activities | (118,569) | (62,817) | (1,061,725) |
| Financing activities | |||
| Proceeds from issue of equity | - | 172,000 | 1,585,000 |
| Net cash generated from financing activities | - | 172,000 | 1,585,000 |
| Net increase/(decrease) in cash and cash equivalents | (233,538) | 24,381 | 307,408 |
| Cash and cash equivalents at beginning of the period | 313,236 | 5,828 | 5,828 |
| Cash and cash equivalents at end of the period | 79,698 | 30,209 | 313,236 |
Final Results, published 27 Feb 26 · read the announcement ↗
Statement of Comprehensive Income · For the year ended 30 September 2025
| 2025 £ | 2024 £ | |
|---|---|---|
| Revenue | - | - |
| Loss on disposal of investments | - | (17,536) |
| Fair valuation movements in financial instruments designated at fair value through profit or loss | (346,928) | (4,312,519) |
| (346,928) | (4,330,055) | |
| Share based payments | (126,700) | - |
| Administrative expenses | (193,257) | (162,309) |
| Operating loss | (666,885) | (4,492,364) |
| Finance income | 1,279 | 398 |
| Loss before and after taxation and total comprehensive loss for the year | (665,606) | (4,491,966) |
| Loss per ordinary share | ||
| Basic loss per share on loss for the year | (1.93p) | (0.09p) |
| Diluted loss per share on loss for the year | (1.93p) | (0.09p) |
Statement of Financial Position · For the year ended 30 September 2025
| 2025 £ | 2024 £ | |
|---|---|---|
| Non-current assets | ||
| Financial assets at fair value through profit or loss | 1,553,643 | 970,394 |
| Total non-current assets | 1,553,643 | 970,394 |
| Current assets | ||
| Loan receivable | 1,015,246 | - |
| Trade and other receivables | 11,252 | 3,308 |
| Cash and cash equivalents | 313,236 | 5,828 |
| Total current assets | 1,339,734 | 9,136 |
| Total assets | 2,893,377 | 979,530 |
| Current liabilities | ||
| Trade and other payables | 27,482 | 42,149 |
| Total liabilities | 27,482 | 42,149 |
| Net assets | 2,865,895 | 937,381 |
| Shareholders' equity | ||
| Share capital | 47,554 | 4,992,774 |
| Share premium account | 11,920,403 | 9,575,072 |
| Deferred shares | 5,067,309 | - |
| Other reserves | 369,948 | 243,248 |
| Retained earnings | (14,539,319) | (13,873,713) |
| Total shareholders' equity | 2,865,895 | 937,381 |
Cash Flow Statement · For the year ended 30 September 2025
| 2025 £ | 2024 £ | |
|---|---|---|
| Operating activities | ||
| Profit/(loss) for the year | (665,606) | (4,491,966) |
| Adjustments | ||
| Finance income | (1,279) | (398) |
| Fair value losses | 346,928 | 4,312,519 |
| Loss on disposal of investments | - | 17,536 |
| Share based payment | 126,700 | - |
| Working capital adjustments | ||
| (Increase)/decrease in trade and other receivables | (7,943) | 3,151 |
| (Decrease)/increase in trade and other payables | (14,667) | 10,073 |
| Net cash used in operating activities | (215,867) | (149,085) |
| Investing activities | ||
| Proceeds from sale of investments | - | 51,660 |
| Purchase of convertible loan note | - | (60,303) |
| Purchase of safe note | (63,004) | - |
| Loan given to SatoshiPay | (1,000,000) | - |
| Interest received | 1,279 | 398 |
| Net cash used in investing activities | (1,061,725) | (8,245) |
| Financing activities | ||
| Proceeds from issue of shares (net) | 1,585,000 | 100,000 |
| Net cash generated from financing activities | 1,585,000 | 100,000 |
| Net decrease in cash and cash equivalents | 307,408 | (57,330) |
| Cash and cash equivalents at start of the year | 5,828 | 63,158 |
| Cash and cash equivalents at end of the year | 313,236 | 5,828 |
As published in the company's results announcement: every line, heading and subtotal, read automatically from the text. Figures in brackets are negative; units as stated in the column headings.
Latest report: H1 Mar 26 (six months to 31 Mar 26), published 30 Jun 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Mar 26 | FY Sep 25 | FY Sep 24 | |
|---|---|---|---|
| Revenue to operating profit | |||
| Operating profit | (1.1) | (0.7) | (4.5) |
| Share-based payments | (0.1) | (0.1) | – |
| Operating profit to net income | |||
| Fair value gains / losses | (0.3) | (0.3) | (4.3) |
| Profit before tax | (1.1) | (0.7) | (4.5) |
| Net income (owners) | (1.1) | (0.7) | (4.5) |
| Per share | |||
| EPS basic | (2.8p) | (1.9p) | (0.1p) |
| EPS diluted | (2.8p) | (1.9p) | (0.1p) |
| H1 Mar 26 | vs H1 Mar 25 | H2 Sep 25 | H1 Mar 25 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 0.0 | n/m | – | 0.0 |
| Exceptional / adjusting items | (0.4) | n/m | – | 0.0 |
| Operating profit | (0.6) | n/m | (0.6) | (0.1) |
| Share-based payments | (0.0) | n/m | (0.1) | (0.0) |
| Operating profit to net income | ||||
| Fair value gains / losses | 0.0 | n/m | (0.3) | (0.0) |
| Profit before tax | (0.6) | n/m | (0.6) | (0.1) |
| Net income (owners) | (0.6) | n/m | (0.6) | (0.1) |
| Per share | ||||
| EPS basic | (1.2p) | – | (1.6p) | (0.4p) |
| EPS diluted | (1.2p) | – | (1.6p) | (0.4p) |
| Latest Mar 26 | FY Sep 25 | FY Sep 24 | |
|---|---|---|---|
| Non-current assets | |||
| Other investments | 2.3 | 1.6 | – |
| Non-current assets | 2.3 | 1.6 | 1.0 |
| Current assets | |||
| Trade receivables | 0.0 | 0.0 | 0.0 |
| Cash | 0.1 | 0.3 | 0.0 |
| Current assets | 0.1 | 1.3 | 0.0 |
| Total assets | 2.3 | 2.9 | 1.0 |
| Current liabilities | |||
| Trade payables | 0.0 | 0.0 | 0.0 |
| Current liabilities | 0.0 | 0.0 | – |
| Non-current liabilities | |||
| Non-current liabilities | 0.0 | 0.0 | – |
| Total liabilities | 0.0 | 0.0 | 0.0 |
| Equity | |||
| Total equity | 2.3 | 2.9 | 0.9 |
| Net cash and other figures | |||
| Net asset value | – | 2.9 | 0.9 |
| H1 Mar 26 | H2 Sep 25 | H1 Mar 25 | H2 Sep 24 | |
|---|---|---|---|---|
| Non-current assets | ||||
| Other investments | 2.3 | 1.6 | 1.0 | – |
| Non-current assets | 2.3 | 1.6 | 1.0 | 1.0 |
| Current assets | ||||
| Trade receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash | 0.1 | 0.3 | 0.0 | 0.0 |
| Current assets | 0.1 | 1.3 | 0.0 | 0.0 |
| Total assets | 2.3 | 2.9 | 1.1 | 1.0 |
| Current liabilities | ||||
| Trade payables | 0.0 | 0.0 | 0.0 | 0.0 |
| Current liabilities | 0.0 | 0.0 | 0.0 | – |
| Non-current liabilities | ||||
| Non-current liabilities | 0.0 | 0.0 | 0.0 | – |
| Total liabilities | 0.0 | 0.0 | 0.0 | 0.0 |
| Equity | ||||
| Total equity | 2.3 | 2.9 | 1.0 | 0.9 |
| Net cash and other figures | ||||
| Net asset value | – | 2.9 | – | 0.9 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.